Asymchem Laboratories Tianjin Co Ltd ADR ASLTY
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $7.45
- Day Range
- $8.15–8.15
- 52-Week Range
- $5.00–8.15
- Bid/Ask
- $0.01 / $492,010.84
- Shares Outstanding
- 723.90M
- Market Cap
- $5.88B
- Volume/Avg
- 100 / 455
Key Statistics
- Price/Earnings (Normalized)
- 37.45
- Price/Sales
- 5.70
- Dividend Yield (Trailing)
- 1.17%
- Dividend Yield (Forward)
- 1.17%
- Dividend Payment Schedule
- Aug
- Total Yield
- 1.17%
Company Profile
Asymchem Laboratories Tianjin Co Ltd is a China-based company, a technology-driven provider of Contract Development and manufacturing organization solutions throughout the drug development and manufacturing process. The group provides clinical-stage CDMO solutions, commercial-stage CDMO solutions, and emerging services. Its operations relate to contract development and manufacturing, which focus on innovation and commercial application of pharmaceutical technology. It has geographic areas in the Chinese Mainland and Overseas.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Large Core
- Total Number of Employees
- 10,617
- Website
- https://www.asymchem.com
Valuation
|
Metric
|
ASLTY
|
|---|---|
Price/Earnings (Normalized) | 37.45 |
Price/Book Value | 2.25 |
Price/Sales | 5.70 |
Price/Cash Flow | 21.67 |
Price/Earnings
ASLTY
Financial Strength
|
Metric
|
ASLTY
|
|---|---|
Quick Ratio | 3.60 |
Current Ratio | 4.56 |
Interest Coverage | 79.42 |
Quick Ratio
ASLTY
Profitability
|
Metric
|
ASLTY
|
|---|---|
Return on Assets (Normalized) | 4.90% |
Return on Equity (Normalized) | 5.69% |
Return on Invested Capital (Normalized) | 4.78% |
Return on Assets
ASLTY
Biotechnology Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Vertex Pharmaceuticals Inc
VRTX
| LOCK|h#Y#XsD | LOCK|H%xZj | $126B | |||
| Moderna Inc
MRNA
| LOCK|w>?kmZ | LOCK|^!z | $90B | |||
| Regeneron Pharmaceuticals Inc
REGN
| LOCK|X@#N^C | LOCK|?V%> | $80B | |||
| argenx SE ADR
ARGX
| LOCK|LKF&C$r | LOCK|l$ | $53B | |||
| BeOne Medicines Ltd ADR
ONC
| LOCK|FtZg>#! | LOCK|!M | $41B | |||
| Alnylam Pharmaceuticals Inc
ALNY
| LOCK|hv>gg#v | LOCK|%xmg! | $30B | |||
| Royalty Pharma PLC Class A
RPRX
| LOCK|$y>%W%< | LOCK|v?nf! | $26B | |||
| Incyte Corp
INCY
| LOCK|>QlhJnW | LOCK|rkw | $23B | |||
| BioNTech SE ADR
BNTX
| LOCK|dr$pRqM | LOCK|bD | $22B | |||
| Jazz Pharmaceuticals PLC
JAZZ
| LOCK|PzfgvKp | LOCK|^^J | $14B |
United States